Efficacy of Medical Treatment for Infantile Hypertrophic Pyloric Stenosis: A Meta-analysis

Infantile hypertrophic pyloric stenosis (IHPS) is a common disease in infancy. Pyloromyotomy is universally considered the treatment for IHPS; however, oral or intravenous atropine has been reappraised for the treatment of IHPS in the past 20 years. We investigated the efficacy of atropine in the me...

Full description

Saved in:
Bibliographic Details
Main Authors: Shu-Fen Wu, Hsiang-Yu Lin, Fu-Kuei Huang, An-Chyi Chen, Bai-Horng Su, Chia-Ing Li, Hung-Chih Lin
Format: Article
Language:English
Published: Elsevier 2016-12-01
Series:Pediatrics and Neonatology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1875957216300262
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849739463173865472
author Shu-Fen Wu
Hsiang-Yu Lin
Fu-Kuei Huang
An-Chyi Chen
Bai-Horng Su
Chia-Ing Li
Hung-Chih Lin
author_facet Shu-Fen Wu
Hsiang-Yu Lin
Fu-Kuei Huang
An-Chyi Chen
Bai-Horng Su
Chia-Ing Li
Hung-Chih Lin
author_sort Shu-Fen Wu
collection DOAJ
description Infantile hypertrophic pyloric stenosis (IHPS) is a common disease in infancy. Pyloromyotomy is universally considered the treatment for IHPS; however, oral or intravenous atropine has been reappraised for the treatment of IHPS in the past 20 years. We investigated the efficacy of atropine in the medical management of IHPS by using meta-analysis and investigated the sonographic changes of the pyloric canal, as well as the efficacy and adverse effects of atropine. Methods: Information was retrieved from PubMed, Ovid, and MEDLINE. The efficacy and adverse effects of atropine treatment for IHPS were reviewed using the standard process of meta-analysis. Results: Eleven articles were obtained. Five reports showed that 77 of 110 (70%) infants who were administered oral atropine benefitted by the induced remission of IHPS. Six reports showed that 288 of 345 (83.5%) patients who were treated initially with intravenous atropine then changed to oral atropine showed beneficial effects and had no serious side effects. Time to pyloric muscle normalization ranged from 5 weeks to 15 months. Conclusion: The study results indicate that atropine is a possible alternative treatment for IHPS, particularly in infants with major concurrent disease, and is safe without obvious side effects.
format Article
id doaj-art-40db4eb449dd4ed6b37f1946b2af3351
institution DOAJ
issn 1875-9572
language English
publishDate 2016-12-01
publisher Elsevier
record_format Article
series Pediatrics and Neonatology
spelling doaj-art-40db4eb449dd4ed6b37f1946b2af33512025-08-20T03:06:16ZengElsevierPediatrics and Neonatology1875-95722016-12-0157651552110.1016/j.pedneo.2016.02.005Efficacy of Medical Treatment for Infantile Hypertrophic Pyloric Stenosis: A Meta-analysisShu-Fen Wu0Hsiang-Yu Lin1Fu-Kuei Huang2An-Chyi Chen3Bai-Horng Su4Chia-Ing Li5Hung-Chih Lin6Department of Pediatrics, China Medical University Children's Hospital, Taichung, TaiwanDepartment of Pediatrics, China Medical University Children's Hospital, Taichung, TaiwanDepartment of Pediatrics, China Medical University Children's Hospital, Taichung, TaiwanDepartment of Pediatrics, China Medical University Children's Hospital, Taichung, TaiwanDepartment of Pediatrics, China Medical University Children's Hospital, Taichung, TaiwanSchool of Medicine, China Medical University, Taichung, TaiwanDepartment of Pediatrics, China Medical University Children's Hospital, Taichung, TaiwanInfantile hypertrophic pyloric stenosis (IHPS) is a common disease in infancy. Pyloromyotomy is universally considered the treatment for IHPS; however, oral or intravenous atropine has been reappraised for the treatment of IHPS in the past 20 years. We investigated the efficacy of atropine in the medical management of IHPS by using meta-analysis and investigated the sonographic changes of the pyloric canal, as well as the efficacy and adverse effects of atropine. Methods: Information was retrieved from PubMed, Ovid, and MEDLINE. The efficacy and adverse effects of atropine treatment for IHPS were reviewed using the standard process of meta-analysis. Results: Eleven articles were obtained. Five reports showed that 77 of 110 (70%) infants who were administered oral atropine benefitted by the induced remission of IHPS. Six reports showed that 288 of 345 (83.5%) patients who were treated initially with intravenous atropine then changed to oral atropine showed beneficial effects and had no serious side effects. Time to pyloric muscle normalization ranged from 5 weeks to 15 months. Conclusion: The study results indicate that atropine is a possible alternative treatment for IHPS, particularly in infants with major concurrent disease, and is safe without obvious side effects.http://www.sciencedirect.com/science/article/pii/S1875957216300262atropineinfantile hypertrophic pyloric stenosispyloromyotomy
spellingShingle Shu-Fen Wu
Hsiang-Yu Lin
Fu-Kuei Huang
An-Chyi Chen
Bai-Horng Su
Chia-Ing Li
Hung-Chih Lin
Efficacy of Medical Treatment for Infantile Hypertrophic Pyloric Stenosis: A Meta-analysis
Pediatrics and Neonatology
atropine
infantile hypertrophic pyloric stenosis
pyloromyotomy
title Efficacy of Medical Treatment for Infantile Hypertrophic Pyloric Stenosis: A Meta-analysis
title_full Efficacy of Medical Treatment for Infantile Hypertrophic Pyloric Stenosis: A Meta-analysis
title_fullStr Efficacy of Medical Treatment for Infantile Hypertrophic Pyloric Stenosis: A Meta-analysis
title_full_unstemmed Efficacy of Medical Treatment for Infantile Hypertrophic Pyloric Stenosis: A Meta-analysis
title_short Efficacy of Medical Treatment for Infantile Hypertrophic Pyloric Stenosis: A Meta-analysis
title_sort efficacy of medical treatment for infantile hypertrophic pyloric stenosis a meta analysis
topic atropine
infantile hypertrophic pyloric stenosis
pyloromyotomy
url http://www.sciencedirect.com/science/article/pii/S1875957216300262
work_keys_str_mv AT shufenwu efficacyofmedicaltreatmentforinfantilehypertrophicpyloricstenosisametaanalysis
AT hsiangyulin efficacyofmedicaltreatmentforinfantilehypertrophicpyloricstenosisametaanalysis
AT fukueihuang efficacyofmedicaltreatmentforinfantilehypertrophicpyloricstenosisametaanalysis
AT anchyichen efficacyofmedicaltreatmentforinfantilehypertrophicpyloricstenosisametaanalysis
AT baihorngsu efficacyofmedicaltreatmentforinfantilehypertrophicpyloricstenosisametaanalysis
AT chiaingli efficacyofmedicaltreatmentforinfantilehypertrophicpyloricstenosisametaanalysis
AT hungchihlin efficacyofmedicaltreatmentforinfantilehypertrophicpyloricstenosisametaanalysis